COMPLERA (tenofovir disoproxil fumarate) Patient Assistance Program
Don’t let the cost of Complera disrupt your HIV treatment. Between Gilead’s Advancing Access programs, the Ryan White/ADAP safety net, and the first generic version launched in 2025, an affordable route exists for nearly everyone. We find yours and manage the enrollment for a flat $69.95 per month.
- Clear & Transparent Pricing — Applying To Gilead Directly Is Always Free
- Paperwork, Documentation & Doctor-Coordination Handled For You
- Comprehensive Support: From Application To Entire Journey
- Annual Re-Certification And Refills Management
- Ryan White & ADAP Navigation — The Route Most Patients Miss
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Complera Is A Complete Once-Daily Single-Tablet HIV-1 Regimen Combining Emtricitabine, Rilpivirine, And Tenofovir DF — Taken With A Full Meal, For Patients With Viral Loads Under 100,000 Copies At The Start Of Treatment.
- The 2025 Milestone: The First AB-Rated Generic Of The Full Complera Combination Launched In June 2025 (Viatris/Mylan), With A Second Approval In March 2026 — The First Real Price Competition This Regimen Has Ever Had.
- Gilead’s Advancing Access Program Provides Free Medication To Eligible Uninsured Patients On 12-Month Enrollments, And The Advancing Access Co-Pay Program Covers Commercially Insured Patients Up To $6,000 Per Year.
- HIV Patients Have A Safety Net Most Categories Don’t: Complera Sits On State ADAP Formularies Under The Ryan White Program, Antiretrovirals Are A Protected Medicare Class, And The $2,100 Part D Cap (2026) Bounds Annual Costs.
What Is Complera Prescription Assistance Program?
The Complera Patient Assistance Program is run through Gilead Advancing Access (1-800-226-2056, Mon–Fri 9 AM–8 PM ET), which provides Complera free of charge to eligible uninsured patients — U.S. residents who document income and aren’t eligible for Medicaid or ADAP coverage they should be using first — on 12-month renewable enrollments. But for HIV medication, the manufacturer program is one layer of three: the federal Ryan White Program and state ADAPs cover Complera on most formularies for income-eligible patients (often paying premiums and copays too), and since June 2025 an AB-rated generic of the full combination has been on the market, bringing the first price competition in the regimen’s history. Sequencing these — ADAP first where it applies, Advancing Access where it doesn’t, the generic where your plan prefers it — is exactly the kind of navigation that keeps treatment uninterrupted, and interruption is the one thing HIV therapy cannot tolerate. For a flat $69.95 per month, our Patient Advocates run all three layers and every renewal.
Pharmacy Price Comparison
- Without assistance, Complera costs roughly $3,100–$3,600/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,500.00 | Save ~$3,430/mo |
| CVS Pharmacy | ~$3,600.00 | Save ~$3,530/mo |
| Walmart | ~$3,200.00 | Save ~$3,130/mo |
| Costco | ~$3,150.00 | Save ~$3,080/mo |
| Kroger | ~$3,200.00 | Save ~$3,130/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Complera Prescription Program?
The Patient Assistance Program is free to apply for and provides Complera at no medication cost if approved. Our $69.95/month service covers full advocacy. With Odefsey (TAF reformulation) widely available, your provider may have considered switching — we can help coordinate.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Complera:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,100–$3,600 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Between the three layers, nearly everyone qualifies for something. For Gilead’s free-medication program specifically, you will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Complera assistance:
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Complera Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Complera}:
Complera combines three antiretrovirals — emtricitabine and tenofovir DF (the classic NRTI backbone) with rilpivirine (an NNRTI) — into one once-daily tablet that suppresses HIV replication at two different points in the viral life cycle.
How Complera Works:
Emtricitabine and tenofovir block reverse transcriptase by masquerading as the building blocks the virus needs to copy its genome; rilpivirine binds the same enzyme at a different site and jams it directly. Taken consistently, the combination drives viral load to undetectable — and undetectable means untransmittable (U=U). Complera’s particulars: it’s indicated for patients starting with viral loads under 100,000 copies/mL, and rilpivirine absolutely requires a full meal (at least ~400 calories) to absorb properly — an empty-stomach dose is effectively a partial dose.
Form and Use:
One tablet, once daily, with a meal — same time daily. Rilpivirine interacts with acid reducers: proton-pump inhibitors are contraindicated outright, and H2 blockers and antacids need strict timing separation. These practical rules matter because adherence is everything: missed or malabsorbed doses invite resistance, and resistance closes future options. Many patients have been switched from Complera to newer regimens (Odefsey, Biktarvy) over the years; if you’re still on it and stable, that’s fine — and now cheaper than ever.
Generic Availability:
New and meaningful: the first AB-rated generic of the full combination launched in June 2025 (Viatris/Mylan), with a second manufacturer approved in March 2026. Pricing is still settling below brand and should fall further as competition builds. Ask your pharmacist to price the generic at refill — and note your plan may migrate you to it automatically.
Warnings:
Like all tenofovir DF regimens, Complera carries warnings for kidney function decline and bone mineral density loss — both monitored with routine labs. Critically for co-infected patients: emtricitabine and tenofovir act against hepatitis B, and stopping Complera can trigger severe HBV flares — never stop without your provider managing the transition. Rilpivirine can prolong QT at high doses and interacts with rifampin, certain anticonvulsants, St. John’s wort, and acid reducers. Depression-related mood changes are reported; tell your provider about mood shifts.
FAQ (Frequently Asked Questions)
How Much Does Complera Cost Without Insurance?
Brand runs about $3,940 per 30 tablets — roughly $47,000 per year. Eligible uninsured patients can receive it free through Gilead Advancing Access, ADAP covers income-eligible patients in every state, and the 2025 generic is pricing below brand. Our $69.95 monthly fee covers sequencing all three correctly.
Is There A Generic For Complera?
Yes — the first AB-rated generic of the full combination launched in June 2025, with a second approval in March 2026. It’s substitutable at the pharmacy; pricing is still finding its floor as competition builds.
What Is ADAP And Should I Apply?
Every state runs an AIDS Drug Assistance Program under the federal Ryan White Program, and Complera sits on most state formularies. ADAPs cover medications — often premiums and copays too — at income limits that are more generous than most patients assume. Checking ADAP first is standard practice; we run the screening as part of enrollment.
Does Medicare Cover Complera?
Yes — antiretrovirals are a protected class, so every Part D plan must cover it, and the $2,100 annual cap (2026) bounds your total drug spending, spreadable monthly via the payment plan. The Gilead copay card can’t be used with Medicare, but Extra Help and ADAP both can.
Can I Use The Gilead Copay Program?
If you’re commercially insured, yes — up to $6,000 per year for Complera, taking most patients to $0 per fill. It excludes all government insurance and cash payers.
Will Anyone Find Out I’m Using These Programs?
Applications are bound by the same privacy laws as your care, and go to program administrators — not employers or landlords. We handle every document confidentially; privacy worries stop too many people from claiming benefits they’re entitled to.
What If My Application Is Denied?
Denials are usually about documentation — income proof, residency, or Medicaid/ADAP-eligibility questions the program wants resolved first. Applications can be corrected and resubmitted, and ADAP usually runs as the parallel path. We review the denial letter, fix what triggered it, and resubmit on your behalf.
Take Control of Your Medication Costs
Between Advancing Access, ADAP, a protected Medicare class, and the first generic in the regimen’s history, Complera has more affordability routes in 2026 than ever — the work is sequencing them right and never letting a renewal lapse. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.